UBS Group AG - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 37 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$1,000
-95.7%
4,089
-94.9%
0.00%
Q1 2022$23,000
-11.5%
79,851
-18.0%
0.00%
Q4 2021$26,000
+8.3%
97,378
+85.4%
0.00%
Q3 2021$24,00052,511
+88901.7%
0.00%
Q2 2021$0
-100.0%
59
-100.0%
0.00%
Q1 2021$393,000576,927
+670745.3%
0.00%
Q3 2020$0
-100.0%
86
-99.7%
0.00%
Q2 2020$13,000
-61.8%
25,145
-76.5%
0.00%
Q1 2020$34,000107,222
+28723.1%
0.00%
Q4 2019$0
-100.0%
372
-98.6%
0.00%
Q3 2019$12,00027,427
+4471.2%
0.00%
Q2 2019$0
-100.0%
600
-84.9%
0.00%
Q1 2019$2,000
-84.6%
3,978
-83.2%
0.00%
Q4 2018$13,000
+550.0%
23,636
+3005.9%
0.00%
Q3 2018$2,0007610.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders